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Abstract
Background: Persistent organic pollutants (POPs) in wildlife and humans remain a cause of global
concern, both in regard to traditional POPs, such as the polychlorinated biphenyls (PCBs), and
emerging POPs, such as the polybrominated diphenyl ethers (PBDEs). To determine the time
related concentrations, we analyzed human milk for these substances at three time points between
1987 and 1999. Polychlorobiphenylols (OH-PCBs), the dominating class of PCB metabolites, some
of which are known to be strongly retained in human blood, were also included in the assessment.
Methods: We obtained milk from the Faroe Islands, where the population is exposed to POPs
from their traditional diet (which may include pilot whale blubber). In addition to three pools, nine
individual samples from the last time point were also analyzed. After cleanup, partitioning of neutral
and acidic compounds, and separation of chemical classes, the analyses were carried out by gas
chromatography and/or gas chromatography/mass spectrometry.
Results: Compared to other European populations, the human milk had high PCB concentrations,
with pool concentrations of 2300 ng/g fat 1987, 1600 ng/g fat in 1994, and 1800 ng/g fat in 1999
(based on the sum of eleven major PCB congeners). The nine individual samples showed great
variation in PCB concentrations. The OH-PCBs were present in trace amounts only, at levels of
approximately 1% of the PCB concentrations. The PBDE concentrations showed a clear increase
over time, and their concentrations in human milk from 1999 are among the highest reported so
far from Europe, with results of individual samples ranging from 4.7 to 13 ng/g fat
Conclusion: Although remote from pollution sources, the Faroe Islands show high concentrations
of POPs in human milk, particularly PCBs, but also PBDEs. The PBDEs show increasing
concentrations over time. The OH-PCB metabolites are poorly transferred to human milk, which
likely is related to their acidic character.
Published: 14 July 2005
Environmental Health: A Global Access Science Source 2005, 4:12 doi:10.1186/
1476-069X-4-12
Received: 12 April 2005
Accepted: 14 July 2005
This article is available from: http://www.ehjournal.net/content/4/1/12
© 2005 Fängström et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Environmental Health: A Global Access Science Source 2005, 4:12 http://www.ehjournal.net/content/4/1/12
Page 2 of 9
(page number not for citation purposes)
Background
Even though persistent organic pollutants (POPs) have
been regulated in most countries in the world, in agree-
ment with the Stockholm convention in 2001 [1], the
POPs are still posing a global environmental threat on the
environment, both to wildlife and humans [2,3]. This is
particularly true at hot spot locations and in remote areas
where dietary habits may influence uptake and accumula-
tion of POPs. This can be exemplified with human expo-
sures to polychlorinated biphenyls (PCBs) at two former
PCB production sites in Michalovche, Slovakia, and in
Anniston, Alabama, U.S.A [4,5]. Populations with ele-
vated levels of PCB due to food intake include popula-
tions frequently consuming fish from the Baltic Sea [6,7]
and Lake Michigan, [8,9], Inuits from Northern Quebec
[10,11] and Greenland [12], and the residents of the Faroe
Islands [13,14]. The aim of the present study was to indi-
cate any concentraion changes of two major classes of
environmental contaminants in humans, as determined
in human milk from the Faroe Islands, sampled at three
different time points between 1987 and 1999. The chem-
icals chosen for analysis were PCBs and polybrominated
diphenyl ethers (PBDEs), as well as polychlorobipheny-
lols (OH-PCBs) as the major class of PCB metabolites.
The Faroe Islands is a small community in the North
Atlantic, located north of Scotland, far from industrial
sources of any POPs, including both the PCBs and PBDEs.
The Faroese population is exposed to these substances
through their food, and possibly via goods and products
in their homes and work environment. Their lifestyle is
entirely Western and their diet is generally based on sea-
food. Part of the population has a considerable intake of
traditional local food, such as pilot whale meat and blub-
ber, and seabirds (e.g., fulmar meat and eggs) [13,15,16].
These high-trophic-level marine species are known to con-
tain high concentrations of POPs (e.g. PCBs and PBDEs)
[15-17]. The PBDE concentrations in pilot whale are in a
concentration range similar to those reported in marine
mammals from other parts of the world and considerably
higher than those found in most marine mammals from
the arctic [18,19]. Because of dietary differences among
the Faroese, a wide variability in PCB concentrations is
present. In 1987 milk pools contained 1.8–3.5 µg PCB per
gram fat [20], serum from pregnant Faroese women in
1994 confirmed the overall average, but individual PCB
concentrations ranged from 0.15 up to as much as 22 µg/
g fat [13]. In subjects from the latter study, OH-PCB con-
centrations of 0.019 to 1.8 µg/g fat were reported, thereby
showing the importance of this class of PCB metabolites
retained in human blood [13].
PBDEs were first reported in fish from Sweden [21] and
subsequently in Japan [22] and in human milk from Ger-
many [23]. These initial results have been followed by a
large number of studies world-wide; in humans, fish,
birds and mammals [19,24]. In a time-trend study for
PBDEs in human milk from Sweden from the early 1970s
to 1997, the concentrations showed a significant increase
[25], while samples from 1997 to 2000 indicate a
decrease, mainly due to reduced concentrations of BDE-
47 [26]. A decrease of PBDEs in Swedish milk was also
indicated by Lind and co-workers 2003 [27]. A good over-
view of data on human PBDE exposures were given in
recent reviews, including those by Hites [19], Sjödin et al.
[28] and Ryan [29]. In Norway, PBDE in human milk
increased from 1986 to 2001, with similar concentration
levels to those reported in Sweden and Japan
[25,26,30,31]. In the Canadian Artic, the PBDE concentra-
tions have increased with a factor of 3 during the 1990s
(i.e., from 2.2 to 6.2 ng/g fat) [32]. A similar concentra-
tion range has been reported from the United Kingdom.
In southern Canada, the concentrations were about 3
times higher [29,32], and the PBDE levels reported in
human milk from the United States are about 2–3 times
higher again than those from Southern Canada and ~20
times higher than those seen in Europe and Japan
[19,25,26,29,31,33,34].
PCBs still constitute some of the dominating environmen-
tal contaminants among all POPs [3]. The human concen-
trations of PCBs have decreased over time, even though
the changes seem to be less than for 2,2-bis(4-chlorophe-
nyl)-1,1-dichloroethene (DDE). These reductions in
human PCB concentrations are related to the legislative
measures taken in the 1970s. Temporal studies on the
decrease of PCB levels, as studied in Swedish mothers
milk from the early 1970s through 1997, indicate a 30%
decrease [35]. In Germany, the PCB concentrations in
mother's milk have decreased by 60% from 1986 to 1997
[36]. Also in Germany, Fürst and co-workers showed PCB
decreases of up to 85% from 1984 to 2003 [37] (pers.
comm. P. Fürst). Declining PCB concentrations in human
milk have also been observed in Norway [38] and Canada
[39], with different rates of the decrease in each country.
Materials and methods
Samples
In connection with formation of mother-child pair
cohorts in 1987, 1994/95, and 1999 from consecutive
births at the National Hospital in Tórshavn, Faroe Islands,
milk was collected on days 3–5 post partum and then
deep frozen. For the present study, mothers were selected
from the three cohorts using the following inclusion crite-
ria: age between 20 and 29 years, parity no more than one,
singleton birth, and delivery at term. Similar procedures
were used in 1987, 1994, and 1999 [20,40]. Three pooled
milk samples were generated from the three cohorts, each
containing the same amount of milk from ten mothers (2
ml from each mother). Because dietary habits are
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changing, women were further selected for inclusion in
the study from information on their diet during preg-
nancy. The pooled samples contained milk from four
women who did not eat whale meat at all during preg-
nancy, and two each who ate whale meat once, 2–3 times,
and at least 4 times per month. However, due to lack of
sufficient sample volume, the pool from 1994 contained
milk from only three women who had not eaten whale
meat at all. To determine the full range and variability of
POP exposure, nine individual samples taken from the
same women selected in the pool from the most recent
cohort (1999) were also analysed. Due to limited volumes
of milk available, specimens of at least 10 ml were taken
from the milk samples collected 2–3 weeks after delivery.
Additionally, due to changes in dietary habits in the
Faroese [14], the samples selected from 1999 may not be
fully representative of Faroese pregnant women, but they
are comparable to the previously collected samples, in
regard to traditional dietary habits. All samples were ana-
lyzed for major PBDE, PCB and OH-PCB congeners.
Chemicals
The individual PBDE congeners (numbered according to
Ballschmiter et al. [41]): BDE-47, BDE-77, BDE-99, BDE-
100, BDE-153, BDE-154, and BDE-209 were synthesized
in-house [42]. The individual PCB congeners: CB-101,
CB-105, CB-118, CB-128, CB-138, CB-146, CB-153, CB-
156, CB-170, CB-180, CB-183 and CB-200 [41] were pur-
chased from Larodan Fine chemicals AB in Malmö, Swe-
den. The hydroxylated PCB standards 4-OH-CB146, 4-
OH-CB187 and 4-OH-CB193 were synthesized (as
described elsewhere [43]) and abbreviated according to
Letcher et al. [44]. All solvents were of pro analysis quality.
2-Propanol from AnalaR (BDH laboratory supplies pool,
England) and methyl tert-butyl ether (HPLC-grade; Rath-
burn, Walkerburn, Scotland) were glass-distilled prior to
use. Silica gel (<0.063 mm) was purchased from Merck
(Darmstadt, Germany) and activated (300°C, 12 h)
before use.
Instruments
The PBDE analysis was performed by gas chromatogra-
phy/mass spectrometry (GC/MS) using a Finnigan TSQ
700 instrument (ThermoFinnigan, Bremen, Germany)
connected to a Varian 3400 gas chromatograph equipped
with an AS200S CTC autosampler. The transfer line tem-
perature was set to 290°C and the ion source temperature
maintained at 200°C. On-column injections were made
using a septum-equipped temperature programmable
injector (SPI) fitted with a high performance insert
directly connected to a DB-5 HT capillary column (15 m
× 0.25 mm i.d., 0.1 µm film thickness; J&W Scientific)
with helium as carrier gas at a head pressure of 3 psi. The
injector was temperature programmed from 60°C to
320°C at 150°C/min and the oven from 80°C (1 min),
15°C/min to 300°C (16 min). The PBDE congeners were
analysed with selected ion monitoring (SIM) by scanning
for the negative bromide ion (isotopes m/z 79 and 81)
formed by electron capture reactions at chemical ioniza-
tion (ECNI) with methane (5.0, AGA, Stockholm, Swe-
den) as the electron thermalization buffer gas at 5.6 torr
and a primary electron energy of 70 eV. All chromato-
graphic data were collected, analysed and quantified using
the proprietary ICIS2 software from Thermofinnigan.
The PCB and OH-PCB analyses were performed on a Var-
ian 3400 gas chromatograph, equipped with a Varian
8200 autosampler, an electron capture detector (ECD),
and a split-splitless injector operated in the splitless
mode. Hydrogen was used as a carrier gas and nitrogen as
a make-up gas. A CP-Sil-8-column (25 m × 0.15 mm inter-
nal diameter and 0.12 µm film thickness Chrompack, EA
Middleburg, The Netherlands) was used. For the PCB
analysis, the column temperature was 80°C (1 min),
20°C/min, to 300°C (5 min) and for the OH-PCB analy-
sis the column temperature was 80°C (1 min), 50°C/min,
to 200°C (1 min), 1°C/min, to 230°C, 50°C/min, to
330°C (2 min). The injector temperature was 280°C and
the detector temperature 360°C. The data were collected
using a PC-based ELDS Pro v2.0 system (Chromatograhic
Data System AB, Stockholm, Sweden). The linear relation-
ship of the GC/ECD and GC/MS system was determined
and the quantifications were performed using a single
point external standard within the concentration range of
the linear relationship.
Extraction and cleanup procedure
The extraction and cleanup procedure for the milk sam-
ples is a modified version of a method for serum samples
first described and validated by Hovander and co-workers
[45]. In the modified version of the method, formic acid
and diethyl ether are used instead of hydrochloric acid
and methyl tert-butyl ether. Surrogate standards, BDE-77,
CB-200 and 4-OH-CB193 were added to the samples
prior to extraction. In short, formic acid (1 ml) and 2-pro-
panol (6 ml) were added to a milk sample (5 g), subse-
quently extracted with a mixture of n-hexane/diethyl ether
(1:1, 6 ml), and re-extracted once (3 ml). The lipid con-
tent was determined gravimetrically after gentle evapora-
tion of the solvent. The neutral and phenol-type
compounds were separated by partitioning with a potas-
sium hydroxide solution. The bulk of lipids in the neutral
fraction was removed with concentrated sulfuric acid and
additional cleanup was performed on two subsequently
applied sulfuric acid/silica gel columns, according to Hov-
ander et al. [45]. Potential OH-PCB congeners were deri-
vatized with diazomethane and any remaining lipids in
the methylated phenol fraction were removed as
described elsewhere [45]. All samples were protected from
daylight during handling and storage to prevent any
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photochemical degradation of the brominated com-
pounds to be analyzed.
Solvent blank samples representing every fifth sample
were cleaned up and analyzed in the same way as the
other samples. The PBDEs in the sample had to be three
times greater than the PBDE amount in the blank to be
considered as a quantifiable amount. The average blank
sample amount has been subtracted from the results. The
overall recoveries and standard deviation (SD) of the sur-
rogate standards were 83% ± 6.1 for BDE-77, 83% ± 4.2
for CB-200 and 104% ± 6.7 for 4-OH-CB193.
Recovery experiment
The recovery study was performed on 5 g of cow milk with
a fat content at 3%. Before extraction a selected number of
PBDE congeners were added, BDE-47, BDE-99, BDE-100,
BDE-153, BDE-154 and BDE-209 at two different spike
levels (0.1 ng/sample and 1 ng/sample) both in tripli-
cates. In parallel, six samples were extracted without any
PBDE congeners added. Prior to analysis by GC/MS, the
same PBDE congeners (BDE-47, BDE-99, BDE-100, BDE-
153, BDE-154 and BDE-209) were added to the samples
at the two levels (0.1 ng/sample and 1 ng/sample). These
samples therefore represent 100% of the analytes, and
from these, the absolute recoveries were calculated. In
addition, three more samples were run in parallel as blank
samples for control of any background contamination.
Results
The duplicate results (A/B) for PBDE congener concentra-
tions in pooled milk samples from 1987, 1994/95 and
1999 are presented in Table 1, as are the mean/medians
and ranges for the nine individual samples from 1999. All
PBDE results except for one were above the limit of quan-
tification (LOQ), a single individual milk sample having
a non-detectable BDE-209 concentration. The PBDE
results for all individual samples from 1999 exceed the
pool value from 1987, except for BDE-209 and BDE-154/
BB-153. Likewise, all total PBDE concentrations of the
individual samples exceed the totals from both 1987 and
1994/95. The time related levels of PBDEs (Fig. 1) there-
fore seems to reflect a real and substantial increase. While
this is obvious for BDE-47, an even more dramatic
increase has occurred for BDE-153, especially when com-
pared to relevant data from Sweden (Fig. 2).
The concentrations of eleven major PCB congeners in
pooled milk samples and the median and ranges for the
nine individual samples from 1999 are given in Table 2.
All concentration data are presented both on a weight and
molar basis to promote correct comparisons of concentra-
tions of these compounds with their highly different
molar masses. In contrast to the tendency seen in PBDE
concentrations, the PCB results are rather stable (Fig. 3),
with the three pools showing quite similar results, and all
pool data well within the variability seen in the individual
samples from 1999.
Table 1: Concentrations of the PBDE congeners identified in human milk from the Faroe Islands. The samples were pooled with ten 
mothers in each pool, two samples (A/B) of the same pool were analyzed in parallel. ΣPBDE consist of BDE-47, BDE-99, BDE-100, 
BDE-153 and BDE-209.
Concentration (ng/g fat) Concentration (pmol/g fat)
Year 1987 1994/95 1999 1999 1987 1994/95 1999 1999
Samples (A/B)a (A/B)a (A/B)a n = 9b (A/B)a (A/B)a (A/B)a n = 9b
mean/median 
(range)
mean/median 
(range)
BDE-47 0.37/0.40 1.1/1.1 1.7/1.6 1.9/1.3 (0.90–
4.5)
0.77/0.83 2.2/2.2 3.5/3.4 4.0/2.6 (1.8–
9.2)
BDE-99 0.15/0.17 0.50/0.51 0.91/0.94 0.84/0.73 
(0.33–1.8)
0.26/0.30 0.88/0.90 1.6/1.7 1.5/1.3 (0.59–
3.3)
BDE-100 0.23/0.26 0.58/0.59 0.92/0.96 1.0/0.58 
(0.30–2.8)
0.41/0.45 1.0/1.1 1.6/1.7 1.8/1.0 (0.53–
4.9)
BDE-153 0.57/0.65 1.4/1.4 3.3/3.6 2.4/2.1 (1.5–
3.8)
0.89/1.0 2.1/2.2 5.1/5.5 3.8/3.2 (2.3–
6.0)
BDE-209 0.59/0.59 0.47/0.55 1.1/1.3 1.0/0.60 
(<0.14c–3.2)
0.62/0.62 0.49/0.58 1.2/1.3 1.1/0.63 
(<0.15c–3.4)
ΣPBDE 1.9/2.1 4.0/4.2 8.0/8.4 7.2/5.8 (4.7–
13)
2.9/3.2 6.8/6.9 13/14 12/8.9 (7.9–
23)
BDE-154/BB-
153
1.8/2.1 1.8/1.8 2.5/2.6 1.9/1.3 (0.66–
4.0)
2.9/3.3 2.7/2.8 3.9/4.0 3.0/2.1 (1.0–
6.3)
aThe samples were pooled with 10 mothers in each pool, two samples of the same pool were analyzed in parallel.
bThe nine individual samples are the same samples as those included in the pool, except one missing.
cLOQ for BDE-209
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Concentrations of two individual OH-PCB congeners (4-
OH-CB146 and 4-OH-CB187) detected for all samples
analyzed are presented in Table 2 (bottom). The ratio
between the dominating OH-PCB metabolite and the PCB
congener present in the highest concentration, 4-OH-
CB187/CB-153 in the milk was below 0.002 in all cases.
The recoveries of BDE-47, BDE-99, BDE-100, BDE-153,
BDE-154 and BDE-209 (Table 3) were about 90%, within
a range of 79–107%, except for BDE-209 for which the
recovery range was somewhat wider (86–160%). As an
additional reflection of the analytical quality, the mean
concentrations of the nine individual samples are very
close to the value obtained from the pool, despite the fact
that one of the single samples was lost. Although the indi-
vidual samples were selected to represent differences in
recent diets, there was no clear association between recent
diet and the POP results obtained.
Discussion
The concentrations of each of the PBDE congeners appear
to increase substantially in human milk from the Faroese
women studied between 1987 and 1999 (Table 1 and Fig.
1), most likely independent of a skewed sampling strat-
egy. The variability of the ΣPBDE concentrations is appar-
ent from analyses of the nine individual samples from the
most recent group of samples (1999). The rather wide
range between the highest and the lowest ΣPBDE concen-
tration could conceivably be due to differences in life style
and dietary habits, as has previously been demonstrated
for PCB concentrations. Other studies have also revealed
high variations in PBDE concentrations between individ-
uals [27,34,46,47]. Previous studies have also shown
increasing PBDE concentrations with time. For example,
Merionyté and co-workers [25,26] showed a similar trend
for BDE-47, but a very different trend for BDE-153 (Fig.
2). The apparent high concentrations and/or increase over
time of BDE-153 in the Faroese is more pronounced than
reported in most previous studies [28,31,34] even though
this congener has occasionally been shown to dominate
among the PBDE congeners in blood from humans in the
Netherlands [47] and the human milk from the U.S. [48].
Very recently BDE-153 was pointed out as the most com-
mon PBDE congener in a few human adipose tissue sam-
ples [49]. The pattern with a high concentration of BDE-
153 was seen in seven out of nine of the individual milk
samples from 1999. The other PBDE congeners were
present at concentration levels as expected from previ-
ously published data.
BDE-209 is a PBDE congener with an apparent short half-
life (15 days) [50], and its presence in concentrations up
to 3.2 ng/g fat, with only one sample below LOQ (Table
1) is an indication of continuous exposure to this PBDE
congener. The median concentration of BDE-209 in 1999
is approximately half the concentration in serum from
Swedish abattoir workers (2.5 ng/g fat) from 2000 [51].
BDE-209 was also recently detected at very low concentra-
tions in some human milk samples from Germany col-
lected in 2001–2003, with a median at 0.1 ng/g fat [52]. A
mean of 0.9 ng/g fat was found in U.S. mothers [34], but
only seven samples out of 47 were above the LOQ. In the
Faroese milk samples, BDE-209 was above LOQ in all but
one sample and at a mean concentration of approx. 1 ng/
g fat at the last time point 1999. This is twice the concen-
PBDE concentrations in pooled milk samples from the Faroese generated in 1987, 1994/95 and 1999igure 1
PBDE concentrations in pooled milk samples from the 
Faroese generated in 1987, 1994/95 and 1999. PBDE conge-
ner (BDE-47, BDE-99, BDE-100, BDE-153 and BDE-209) 
concentrations (pmol/g fat) in three pooled milk samples 
from mother-child pair cohorts generated in 1987, 1994/95 
and 1999. Each pool consisted of 10 mothers and two sam-
ples from the same pool were analyzed in parallel.
A time related comparison of BDE-47 and BDE-153 in Swed-ish oth r's milk and the present studyFigur  2
A time related comparison of BDE-47 and BDE-153 in Swed-
ish mother's milk and the present study. Three pooled milk 
samples from mother-child cohorts generated in 1987, 1994/
95 and 1999 from the Faroe Islands are compared to the 
Swedish pooled milk samples [25,26].
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trations of the milk pools from 1987 and 1994/95 (Table
1).
The ΣPBDE median concentrations of the nine individual
samples and the level of the pool sample of the Faroe
Islands mother's milk from 1999 are in the same range as
milk samples from the United Kingdom mothers sampled
in 2002 [33] and German samples from 2002 [53], but
higher than those reported by Fürst and co-workers from
southern Germany [37]. The Faroese human milk PBDE
levels are intermediate between European and North
American concentrations, with the exceptions mentioned
[34]. Even though it may be convenient to compare over-
all ΣPBDE concentrations, individual PBDE congener
concentrations (Fig. 1) are much more important, because
the compounds differ in their toxicities. Depending on
the large molecular weight span of the PBDE congeners,
and given the high atomic weight of bromine, the PBDE
congener concentrations are most correctly reported on a
molar basis and accordingly comparisons are most cor-
rectly done this way.
The PCB concentrations (Table 2) in the Faroese human
milk are considerably higher than those reported from
other studies of human milk (e.g., in Sweden and
Belgium), which are exceeded by a factor of about five in
Table 2: Concentrations of the PCB and OH-PCB congeners identified in human milk from the Faroe Islands. The samples were 
pooled with 10 mothers in each pool, duplicate samples (A/B) were analyzed in parallel. ΣPCB consists of CB-105, CB-118, CB-128, 
CB-138, CB-146, CB-153, CB-156, CB-170, CB- 180, CB-183 and CB-187 and ∑OH-PCB is the sum of 4-OH-CB146 and 4-OH-CB187.
Concentration (ng/g fat) Concentration (pmol/g fat)
Year 1987 1994/95 1999 1999 1987 1994/95 1999 1999
Samples (A/B)a (A/B)a (A/B)a n = 9b (A/B)a (A/B)a (A/B)a n = 9b
mean/median (range) mean/median (range)
CB-105 32/39 28/27 27/32 31/19 (9.6–89) 98/120 85/83 83/98 95/57 (29–270)
CB-118 170/180 110/110 140/140 150/96 (42–430) 520/560 350/330 430/430 460/300 (130–1300)
CB-128/CB-167 30/31 21/21 22/23 22/17 (8.0–43) 82/85 58/59 62/63 60/48 (22–120)
CB-138 490/510 380/370 420/420 430/350 (160–1100) 1400/1400 1000/1000 1200/1200 1200/970 (450–3100)
CB-146 110/100 83/84 100/100 150/130 (55–450) 290/290 230/230 280/280 420/350 (150–1300)
CB-153 570/610 420/410 470/470 460/380 (180–1100) 1600/1700 1200/1100 1300/1300 1300/1100 (500–3000)
CB-156 85/88 53/50 56/55 52/42 (21–120) 230/240 150/140 150/150 140/120 (59–340)
CB-170 170/170 100/100 110/110 100/80 (41–230) 430/440 270/250 290/290 260/200 (100–570)
CB-180 380/400 250/240 270/270 250/210 (99–550) 970/1000 620/610 690/680 640/530 (250–1400)
CB-183 50/53 38/37 41/41 37/31 (14–88) 130/130 95/94 100/100 95/78 (36–220)
CB-187 160/170 130/130 140/140 130/110 (56–340) 410/420 330/330 360/360 330/270 (140–860)
ΣPCB 2200/2400 1600/1600 1800/1800 1800/1500(690–4600) 6100/6400 4400/4300 4900/4900 5000/4000 (1900–
12000)
4-OH-CB146 0.80/0.87 0.33/0.26 0.35/0.40 0.66/0.36 (0.18–1.7) 2.1/2.3 0.88/0.69 0.93/1.1 1.7/0.96 (0.50–4.4)
4-OH-CB187 1.2/1.3 0.48/0.44 0.50/0.45 0.80/0.42 (0.26–1.8) 3.0/3.1 1.2/1.1 1.2/1.1 2.0/1.0 (0.64–4.5)
ΣOH-PCB 2.0/2.1 0.81/0.70 0.85/0.85 1.4/0.75 (0.45–3.5) 5.1/5.4 2.1/1.8 2.1/2.2 3.7/2.0 (1.1–8.9)
aThe samples were pooled with 10 mothers in each pool, two samples of the same pool were analyzed in parallel
bThe nine individual samples are the same samples as those included in the pool, except one missing.
PCB concentrations in pooled milk samples from the Faroese generated i  1987, 1994/95 and 1999Figu e 3
PCB concentrations in pooled milk samples from the Faroese 
generated in 1987, 1994/95 and 1999. PCB congener concen-
trations in pmol/g fat (CB-105, CB-118, CB-128, CB-138, 
CB-146, CB-153, CB-156, CB-170, CB-180, CB-183 and CB-
187) in three pooled milk samples from a mother-child pair 
cohorts generated in 1987, 1994/95 and 1999. Each pool 
consisted of 10 mothers and two samples from the same 
pool were analyzed in parallel.
Environmental Health: A Global Access Science Source 2005, 4:12 http://www.ehjournal.net/content/4/1/12
Page 7 of 9
(page number not for citation purposes)
the milk from the Faroe Islands [35,54]. The PCB time
trend observed in Swedish human milk showed a steady
decrease, with the PCB concentration in 1997 reaching
about 30% of that in 1972 [35]. In Germany, a decline to
10–25% of the PCB concentration occurred from 1984
and 2003 (P. Fürst, pers. comm.). In an Inuit population
(Nunavik, Québec, Canada), the PCB concentration in
cord blood were shown to decrease by about 7% per year
from 1994 to 2001 [11]. All of these studies indicate
decreases of PCBs in contrast to the relatively constant
concentrations found in the present study among women
in the Faroe Islands. However, a wide variation in the
ΣPCB concentration occurs between the individual sam-
ples from the most recent group of the Faroese samples,
and a small average decrease cannot be excluded. The rel-
atively high concentration of CB-118 is notable, although
the human milk PCB profile is dominated by CB-138, -
153 and -180 (Table 2 and Fig. 3). Additional analyses
would be necessary to describe the temporal trend of PCBs
in human samples in the Faroe Islands.
The OH-PCB concentrations are low in mother's milk
(Table 2). This finding is in accordance with results previ-
ously reported from Sweden and in Canada [55,56].
Hence 4-OH-CB187 was the dominating congener, fol-
lowed by 4-OH-CB146 in the Faroese milk. The low con-
centrations are also to be anticipated, because these
metabolites are mainly protein bound in the blood [44]
and not dissolved or partitioned to lipids as are their par-
ent compounds. Accordingly, the OH-PCB exposure of a
nursing child is very low, despite the toxicant being easily
transferred to the fetus [55,57]. These characteristics make
the OH-PCB different from the neutral PCBs and PBDEs.
Despite substantial decreases elsewhere, Faroese human
milk still contains high concentrations of PCBs, with lev-
els in the low ppm range. The major PCB congener in
human milk (CB-153) exceeds the most abundant PBDE
congener (BDE-153) by a factor of 150 in the most recent
samples (Tables 1 and 2). These high PCB concentrations
are likely explained by dietary habits, given that the Faroe
Island population has a high seafood intake, which
includes PCB and PBDE contaminated pilot whale blub-
ber, fulmars and fulmar eggs [15-17].
The high concentrations and unique pattern of PBDEs,
with BDE-153 being the dominant congener, could possi-
bly be explained by a higher persistence of BDE-153 than
of BDE-47. In contrast, pilot whale blubber has been
shown to contain mainly BDE-47, followed by BDE-99,
then BDE-153, thus indicating that this food item may not
be the primary source of human PBDE exposure. Since
fulmars contain only low PBDE concentrations, these
birds also constitute only a minor source for human PBDE
intake. The high PBDE concentrations in 1999 are
unlikely to be explained by exposures to electronic and
electric equipments, since such exposures would not
exceed those present in the rest of Europe. It is possible
that at least some PBDEs are passed through marine food
chains, and that the Faroese are highly exposed from their
traditional seafood diet.
A study from a Northern Canadian population showed
that the traditional food sources in this area did not nec-
essarily result in higher concentrations of PBDEs, as
observed for other persistent organic pollutants (POPs),
such as the PCBs [58]. Arctic mammals, including ringed
seals, have shown relatively low levels of PBDEs, ranging
from 0.40 to 4.3 ng/g fat, as compared to pilot whale
blubber from the Faroe Islands, where PBDE concentra-
tions were 0.84 to 3.2 µg/g fat [17,18]. Still, the fact
remains that residents at the Faroe Islands have high con-
centrations of both PCB and PBDE, and the difficulty in
explaining the sources of the PBDEs suggest that this issue
needs further attention.
The method used for the PBDE analysis in human milk
has previously been used for analysis of PCBs in human
milk and was formerly used also for both organochlorine
and organobrominated compounds in human serum. The
human serum method was adopted for human milk anal-
ysis with a few modifications [45]. The recovery study was
performed with cow's milk [59], because the PBDE con-
centrations in human milk are much higher and would
not be suitable for blank samples. A small pilot study was
performed to confirm that the cow's milk was virtually
free from any PBDEs, which was the case. Milk with 3% fat
was used, because human milk normally has a lipid con-
centration of about that level. The recovery study was
performed only for the PBDEs, because the analytical
method for PCBs has been previously documented [60].
The average recoveries of BDE-47, BDE-99, BDE-100,
BDE-153 and BDE-154 added to the cow milk before
extraction ranged from 79 – 107% (Table 3).
Table 3: Results from the PBDE recovery study performed in 
milk. PBDEs were added at two concentration levels.
Low level a High level b
0.1 ng/sample 1 ng/sample
BDE-47 79 – 82 84 – 86
BDE-99 98 – 100 88 – 88
BDE-100 88 – 90 87 – 88
BDE-153 104 – 107 86 – 94
BDE-154 103 – 107 87 – 92
BDE-209 116 – 160c 86 – 105
a Triplicates samples b Double samples c Only double samples
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Conclusion
This study reports PBDE concentrations in human milk
from the Faroe Islands, for the first time. A steep increase
of PBDE concentrations is shown from 1987 to 1999, and
the concentrations in milk from the late 1990s are among
the highest in Europe. The PBDE pattern is different from
the one reported elsewhere, with BDE-153 as the domi-
nant congener, rather than BDE-47 [25,30]. The PBDE
sources for the Faroese population still need to be identi-
fied, but could include food items affected by passage
through marine food chains. Furthermore, the PCB con-
centrations remain high in Faroese mother's milk with no
clear decrease over time up to the late 1990s. The hydrox-
ylated metabolites of PCBs are poorly transferred to
mother's milk leading to very low exposures to these
metabolites via the milk.
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